ililigtas Craft, Suter score 18 as Miami (OH) knocks off Siena 70-58

Ocular Hypertension Pipeline Forecast 2024: FDA Approvals, Therapies, Mechanism of Action, Route of Administration, and Developments | Laboratoires Thea, Rigshospitalet, Amneal Pharmaceuticals, Theratocular Biotek Co., Alcon Research, Otsuka Beijing Resea 11-22-2024 09:27 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ocular Hypertension pipeline constitutes 70+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Ocular Hypertension Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Ocular Hypertension Market. The Ocular Hypertension Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Ocular Hypertension Pipeline Report: https://www.delveinsight.com/sample-request/ocular-hypertension-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Ocular Hypertension treatment therapies with a considerable amount of success over the years. •Ocular Hypertension companies working in the treatment market are Laboratoires Thea, Rigshospitalet, Amneal Pharmaceuticals, Theratocular Biotek Co., Alcon Research, Otsuka Beijing Research Institute, Qlaris Bio, Inc., Nicox Ophthalmics, Ocuphire Pharma, Santen Inc., Ono Pharmaceutical, MediPrint Ophthalmics, Visiox Pharma, Sun Pharma Advanced Research Company, JeniVision, Inc., Glaukos Corporation, D. Western Therapeutics Institute, Inc., AbbVie, TearClear Corp, Ocular Therapeutix, Inc., Perfuse Therapeutics, Inc., and others, are developing therapies for the Ocular Hypertension treatment •Emerging Ocular Hypertension therapies in the different phases of clinical trials are- LUMIGAN®, TO-O-1001, AR-17043, OPC-1085EL, QLS-111, NCX 470, Nyxol, Sepetaprost(DE-126/ONO-9054/STN1012600 ), LL-BMT1, PDP-716, V-GL1, NCX 470, Kinezodianone R hydrochloride, G2-TR intraocular implant containing travoprost, H-1337, AGN-193408 SR, Latanoprost ophthalmic solution, OTX-TIC, PER-001, and others are expected to have a significant impact on the Ocular Hypertension market in the coming years. •In November 2024, MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company based in San Diego, has announced the results of its Phase 2b clinical trial for LL-BMT1. Utilizing an innovative 3D-printed, drug-eluting contact lens designed for sustained delivery of bimatoprost and hyaluronic acid, the trial successfully met all Phase 2b endpoints. Presented by Dr. Ian Ben Gaddie at the American Academy of Optometry's annual meeting in Indianapolis, the findings highlighted LL-BMT1's potential as a groundbreaking solution for managing mild to moderate glaucoma while enhancing contact lens comfort by alleviating dry eye symptoms. •In April 2024, Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company dedicated to improving vision and quality of life through innovative treatments for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other eye disorders, has announced positive Phase 2 results for PAXTRAVA (travoprost intracameral implant or OTX-TIC) in patients with open-angle glaucoma or ocular hypertension. Ocular Hypertension Overview Ocular hypertension refers to elevated intraocular pressure (IOP) within the eye that exceeds the normal range, typically above 21 mmHg, without causing detectable damage to the optic nerve or vision loss. It is a significant risk factor for developing glaucoma, particularly open-angle glaucoma. Ocular hypertension occurs when the eye's aqueous humor drainage is impaired, leading to increased fluid buildup and pressure. Common risk factors include age, family history, thin corneas, and certain medications. Early detection and management are crucial to prevent progression to glaucoma, often involving regular monitoring and medications to lower IOP. Get a Free Sample PDF Report to know more about Ocular Hypertension Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/ocular-hypertension-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging Ocular Hypertension Drugs Under Different Phases of Clinical Development Include: •T4090: Laboratoires Thea •Xalatan: Rigshospitalet •Reference - LUMIGAN®: Amneal Pharmaceuticals •TO-O-1001: Theratocular Biotek Co. •AR-17043: Alcon Research •OPC-1085EL: Otsuka Beijing Research Institute •QLS-111: Qlaris Bio, Inc. •NCX 470: Nicox Ophthalmics •Nyxol: Ocuphire Pharma •Sepetaprost(DE-126/ONO-9054/STN1012600 ): Santen Inc. /Ono Pharmaceutical •LL-BMT1: MediPrint Ophthalmics •PDP-716: Visiox Pharma/ Sun Pharma Advanced Research Company •JV-GL1: JeniVision, Inc. •NCX 470: Nicox Ophthalmics, Inc. •Kinezodianone R hydrochloride: Laboratoires Thea •G2-TR intraocular implant containing travoprost: Glaukos Corporation •H-1337: D. Western Therapeutics Institute, Inc. •AGN-193408 SR: AbbVie •Latanoprost ophthalmic solution: TearClear Corp •OTX-TIC: Ocular Therapeutix, Inc. •PER-001: Perfuse Therapeutics, Inc. Ocular Hypertension Route of Administration Ocular Hypertension pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Ocular Hypertension Molecule Type Ocular Hypertension Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Ocular Hypertension Pipeline Therapeutics Assessment •Ocular Hypertension Assessment by Product Type •Ocular Hypertension By Stage and Product Type •Ocular Hypertension Assessment by Route of Administration •Ocular Hypertension By Stage and Route of Administration •Ocular Hypertension Assessment by Molecule Type •Ocular Hypertension by Stage and Molecule Type DelveInsight's Ocular Hypertension Report covers around 75+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Ocular Hypertension product details are provided in the report. Download the Ocular Hypertension pipeline report to learn more about the emerging Ocular Hypertension therapies at: https://www.delveinsight.com/sample-request/ocular-hypertension-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Ocular Hypertension Therapeutics Market include: Key companies developing therapies for Ocular Hypertension are - JeniVision, Inc., Nicox Ophthalmics, Inc., Laboratoires Thea, Glaukos Corporation, D. Western Therapeutics Institute, Inc., AbbVie, TearClear Corp, Ocular Therapeutix, Inc., Perfuse Therapeutics, Inc., and others. Ocular Hypertension Pipeline Analysis: The Ocular Hypertension pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Ocular Hypertension with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Ocular Hypertension Treatment. •Ocular Hypertension key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Ocular Hypertension Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Ocular Hypertension market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Ocular Hypertension drugs and therapies- https://www.delveinsight.com/sample-request/ocular-hypertension-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Ocular Hypertension Pipeline Market Drivers •Growing Prevalence, Advancements in Research, Rising Awareness, Regulatory Support, Investment in R&D, are some of the important factors that are fueling the Ocular Hypertension Market. Ocular Hypertension Pipeline Market Barriers •However, High Development Costs, Regulatory Challenges, Limited Patient Compliance, Competitive Landscape, Healthcare Access Disparities, and other factors are creating obstacles in the Ocular Hypertension Market growth. Scope of Ocular Hypertension Pipeline Drug Insight •Coverage: Global •Key Ocular Hypertension Companies: Laboratoires Thea, Rigshospitalet, Amneal Pharmaceuticals, Theratocular Biotek Co., Alcon Research, Otsuka Beijing Research Institute, Qlaris Bio, Inc., Nicox Ophthalmics, Ocuphire Pharma, Santen Inc., Ono Pharmaceutical, MediPrint Ophthalmics, Visiox Pharma, Sun Pharma Advanced Research Company, JeniVision, Inc., Glaukos Corporation, D. Western Therapeutics Institute, Inc., AbbVie, TearClear Corp, Ocular Therapeutix, Inc., Perfuse Therapeutics, Inc., and others •Key Ocular Hypertension Therapies: LUMIGAN®, TO-O-1001, AR-17043, OPC-1085EL, QLS-111, NCX 470, Nyxol, Sepetaprost(DE-126/ONO-9054/STN1012600 ), LL-BMT1, PDP-716, V-GL1, NCX 470, Kinezodianone R hydrochloride, G2-TR intraocular implant containing travoprost, H-1337, AGN-193408 SR, Latanoprost ophthalmic solution, OTX-TIC, PER-001, and others •Ocular Hypertension Therapeutic Assessment: Ocular Hypertension current marketed and Ocular Hypertension emerging therapies •Ocular Hypertension Market Dynamics: Ocular Hypertension market drivers and Ocular Hypertension market barriers Request for Sample PDF Report for Ocular Hypertension Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/ocular-hypertension-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Ocular Hypertension Report Introduction 2. Ocular Hypertension Executive Summary 3. Ocular Hypertension Overview 4. Ocular Hypertension- Analytical Perspective In-depth Commercial Assessment 5. Ocular Hypertension Pipeline Therapeutics 6. Ocular Hypertension Late Stage Products (Phase II/III) 7. Ocular Hypertension Mid Stage Products (Phase II) 8. Ocular Hypertension Early Stage Products (Phase I) 9. Ocular Hypertension Preclinical Stage Products 10. Ocular Hypertension Therapeutics Assessment 11. Ocular Hypertension Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Ocular Hypertension Key Companies 14. Ocular Hypertension Key Products 15. Ocular Hypertension Unmet Needs 16 . Ocular Hypertension Market Drivers and Barriers 17. Ocular Hypertension Future Perspectives and Conclusion 18. Ocular Hypertension Analyst Views 19. Appendix 20. About DelveInsight Related Reports: Ocular Hypertension Market https://www.delveinsight.com/report-store/ocular-hypertension-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Ocular Hypertension Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), Ocular Hypertension Epidemiology https://www.delveinsight.com/report-store/ocular-hypertension-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Ocular Hypertension Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Latest Reports: •Transcatheter Heart Valve Replacement Devices Market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market •Bone Neoplasms Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market •Peak Flow Meters Market: https://www.delveinsight.com/report-store/peak-flow-meters-market •Neuroendoscopy Market: https://www.delveinsight.com/report-store/neuroendoscopy-market •Nosocomial Infections Market: https://www.delveinsight.com/report-store/nosocomial-infections-market •Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.Barclays PLC boosted its position in Franklin BSP Realty Trust, Inc. ( NYSE:FBRT – Free Report ) by 22.0% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 136,534 shares of the company’s stock after purchasing an additional 24,633 shares during the period. Barclays PLC owned about 0.17% of Franklin BSP Realty Trust worth $1,784,000 as of its most recent SEC filing. Other hedge funds also recently made changes to their positions in the company. State Street Corp boosted its position in Franklin BSP Realty Trust by 3.6% during the third quarter. State Street Corp now owns 3,359,241 shares of the company’s stock worth $45,059,000 after purchasing an additional 116,589 shares during the period. Strong Tower Advisory Services lifted its position in Franklin BSP Realty Trust by 28.7% in the third quarter. Strong Tower Advisory Services now owns 1,055,160 shares of the company’s stock valued at $13,780,000 after purchasing an additional 235,548 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Franklin BSP Realty Trust by 13.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,026,290 shares of the company’s stock worth $13,403,000 after purchasing an additional 117,745 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Franklin BSP Realty Trust by 5.9% in the second quarter. Bank of New York Mellon Corp now owns 702,184 shares of the company’s stock valued at $8,848,000 after acquiring an additional 39,000 shares in the last quarter. Finally, 1832 Asset Management L.P. grew its holdings in shares of Franklin BSP Realty Trust by 55.6% during the 2nd quarter. 1832 Asset Management L.P. now owns 700,000 shares of the company’s stock worth $8,820,000 after acquiring an additional 250,000 shares during the period. 59.87% of the stock is currently owned by institutional investors. Analyst Ratings Changes Several analysts recently commented on FBRT shares. Raymond James increased their price objective on shares of Franklin BSP Realty Trust from $15.00 to $15.50 and gave the company a “strong-buy” rating in a research report on Thursday, September 19th. Janney Montgomery Scott initiated coverage on shares of Franklin BSP Realty Trust in a research note on Thursday, December 12th. They set a “buy” rating and a $16.00 target price on the stock. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $15.50. Franklin BSP Realty Trust Stock Down 0.5 % Shares of FBRT opened at $12.68 on Friday. The business has a fifty day moving average of $12.97 and a 200 day moving average of $13.01. The company has a market cap of $1.04 billion, a PE ratio of 15.46 and a beta of 1.40. The company has a quick ratio of 90.45, a current ratio of 90.45 and a debt-to-equity ratio of 3.67. Franklin BSP Realty Trust, Inc. has a 52-week low of $11.99 and a 52-week high of $14.11. Franklin BSP Realty Trust Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Tuesday, December 31st will be paid a $0.355 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.42 dividend on an annualized basis and a yield of 11.20%. Franklin BSP Realty Trust’s payout ratio is 173.17%. About Franklin BSP Realty Trust ( Free Report ) Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). Read More Five stocks we like better than Franklin BSP Realty Trust Profitably Trade Stocks at 52-Week Highs S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains What is the S&P/TSX Index? How AI Implementation Could Help MongoDB Roar Back in 2025 EV Stocks and How to Profit from Them Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon? Receive News & Ratings for Franklin BSP Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Franklin BSP Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter .

After putting out request, Victor Wembanyama plays chess in New York City parkPalo Alto Networks Stock Gets RS Rating Upgrade

Integral Ad Science CFO sells $80,592 in company stock

Pursue Wealth Partners LLC lifted its position in Amazon.com, Inc. ( NASDAQ:AMZN ) by 55.4% in the third quarter, HoldingsChannel.com reports. The firm owned 42,144 shares of the e-commerce giant’s stock after acquiring an additional 15,027 shares during the period. Amazon.com comprises 4.3% of Pursue Wealth Partners LLC’s investment portfolio, making the stock its 5th largest holding. Pursue Wealth Partners LLC’s holdings in Amazon.com were worth $7,853,000 as of its most recent filing with the Securities and Exchange Commission. Other large investors have also modified their holdings of the company. PayPay Securities Corp raised its stake in Amazon.com by 64.6% during the second quarter. PayPay Securities Corp now owns 163 shares of the e-commerce giant’s stock worth $32,000 after acquiring an additional 64 shares in the last quarter. Hoese & Co LLP acquired a new position in Amazon.com during the third quarter worth $37,000. Bull Oak Capital LLC acquired a new position in Amazon.com during the third quarter worth $45,000. Values First Advisors Inc. acquired a new position in Amazon.com during the third quarter worth $56,000. Finally, Christopher J. Hasenberg Inc raised its stake in Amazon.com by 650.0% during the second quarter. Christopher J. Hasenberg Inc now owns 300 shares of the e-commerce giant’s stock worth $58,000 after acquiring an additional 260 shares in the last quarter. 72.20% of the stock is currently owned by institutional investors and hedge funds. Amazon.com Stock Up 2.9 % Shares of Amazon.com stock opened at $227.03 on Friday. The business’s 50 day simple moving average is $197.39 and its 200 day simple moving average is $188.12. Amazon.com, Inc. has a 52-week low of $143.64 and a 52-week high of $227.15. The firm has a market cap of $2.39 trillion, a PE ratio of 48.61, a P/E/G ratio of 1.46 and a beta of 1.16. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.87 and a current ratio of 1.09. Insider Buying and Selling at Amazon.com In other Amazon.com news, CEO Douglas J. Herrington sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $210.00, for a total value of $735,000.00. Following the completion of the transaction, the chief executive officer now directly owns 524,567 shares in the company, valued at $110,159,070. This trade represents a 0.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Also, SVP David Zapolsky sold 2,190 shares of Amazon.com stock in a transaction that occurred on Tuesday, September 24th. The stock was sold at an average price of $195.00, for a total value of $427,050.00. Following the transaction, the senior vice president now owns 62,420 shares of the company’s stock, valued at $12,171,900. This represents a 3.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold a total of 6,030,183 shares of company stock worth $1,252,883,795 over the last ninety days. 10.80% of the stock is currently owned by corporate insiders. Wall Street Analysts Forecast Growth Several research analysts have issued reports on the company. Redburn Atlantic increased their price objective on Amazon.com from $225.00 to $235.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Truist Financial increased their price objective on Amazon.com from $265.00 to $270.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Bank of America increased their target price on Amazon.com from $210.00 to $230.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Morgan Stanley increased their target price on Amazon.com from $210.00 to $230.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, Benchmark increased their target price on Amazon.com from $200.00 to $215.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating, forty-one have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Amazon.com has a consensus rating of “Moderate Buy” and an average target price of $236.20. View Our Latest Research Report on Amazon.com Amazon.com Profile ( Free Report ) Amazon.com, Inc engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. Read More Want to see what other hedge funds are holding AMZN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amazon.com, Inc. ( NASDAQ:AMZN – Free Report ). Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter .Traveling this holiday season? 10 things the TSA wants you to know

( MENAFN - GetNews) Newland Payment technology FlyKey: Remote Key Injection About FlyKey Safe and convenient service FlyKey can integrates us more closely with customers, allows us to further participate in customers use of financial payment products in addition to sell POS terminals to customer, and jointly improves the payment ecological chain. And through safe and convenient services it creates value for customers and achieves a win-win situation. Delivering full security through the cloud, Flykey is a powerful new solution that allows operations with full secure remote key management capabilities, in conformity with the latest payment industry standards. Customer exclusive account Upload and store keys in secure environment Configure the key group and associate with terminals POS remote inject key Features Solve pain points in all aspects FlyKey not only complies with the specification standards throughout the process, but also provides stable eservices and rich scalability. Compared to traditional key injection methods, FlyKey makes everything easier and more cost-effective. Pass PCI PIN 3.1 and P2PE certifications Remote key injection Reduce labor costs Support a large batch of devices to inject keys at one time UPS support, support 7 * 24 hours service Provide rich interfaces for third-party services Safe and efficient management Remote Key InjectionA solution for remote secure flexible inject keys key types:DUKPT, MK/SKSupported POS types:Android/Linux/RTOS Key Security Implement key security, standardization, efficiency, centralized and unified, full life cycle security and compliance management, and include advanced key package management, group management, full monitoring. Terminal Management Provide a better management operation interface and support exporting terminal key inject records. Dashboard Provide visual and up-to-date RKI information, terminal information, and account information. Services & Support In order to meet the customer requirement of using FlyKey in complex environments, and improve the operation experience, we will provide you with comprehensive technical training, and a professional quick response team to solve customer problems timely. Company Overview Newland Payment Technology is dedicated to enabling the digital transformation of commerce through seamless and sustainable solutions, including our cutting-edge payment terminals. With over three decades of experience, we have successfully deployed more than 100 million terminals across 120+ countries and regions. Our primary focus lies in fostering innovation and sustainability, empowering businesses to thrive in the digital economy while minimizing their environmental footprint. Through leveraging robust global partnerships and offering comprehensive services, we are actively building an inclusive and eco-friendly payment ecosystem that drives efficiency, security, and sustainability in commerce. MENAFN17122024003238003268ID1109004734 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Last fall, the Golden State Warriors got an early indication that Brandin Podziemski was no average rookie, and it had nothing to do with his basketball skills. The 6-foot-5 guard, playing in one of his first scrimmages with the team, yelled at Draymond Green -- yes, Draymond Green -- for committing a turnover that cost them the game. While some probably held their breath in anticipation of Green's reaction, the verbal lashing only elicited one feeling in the fiery 12-year veteran: Respect. "Here we are playing a pick-up game, a game to get me ready [to return from injury] and he's yelling at me," Green told The Athletic . "That, to me, said a whole lot. I was like, 'You know what? No problem. But make sure you speak up like that all the time.'" Not a problem. Despite being just 21 years old and in his second NBA season, Podziemski has already become one of the vocal leaders on a team that features the venerated voices of Green and Stephen Curry . As his chestnut tendrils bob up and down above his headband while he dribbles down the floor, Podziemski confidently gesticulates and shouts toward teammates in order to get them organized. His role off the bench is partly why the Warriors have raced out to a 12-4 start, tied for the best record in the Western Conference. "I think the biggest strides I've made is as a leader," Podziemski told CBS Sports. "Being a point guard on the floor, guys -- no matter their age or their status in the league -- kind of look at you on the floor to know what's going on. And so, learning a lot from Steph and seeing how he went about things, learning a lot from Chris Paul last year and how he went about it, helped me now." From the way he dealt with Green early in his career, to the way he answers questions, to simply the way he stands -- goateed chin held high and shoulders assertively back -- Podziemski exudes confidence well beyond his years. Last season, Warriors head coach Steve Kerr even went as far as to call him "cocky," meant as the best compliment possible. But Podziemski's self-assured nature doesn't mean he thinks he's perfect. Far from it. And a good example is the smile he prominently displays when his team accomplishes something brilliant on the court. Podziemski is using Invisalign treatment to straighten out the teeth that, to him, could use some improvement. He had braces as a young man but they didn't quite do the trick. "With anything that you want done for yourself, or things that you're doing, when you feel good, you're more confident," Podziemski told CBS Sports in an interview set up by Invisalign. "And so, yeah, I'm a confident person, but there's always room for improvement." Podziemski's smile may already be looking better, but he hasn't had much reason to display it on the court this season. An All-Rookie selection last year, he's shooting just 37% from the field and a jarring 18.5% from 3-point range, down 20% from his accuracy rate from deep as a rookie. Kerr has made headlines for playing 11- or 12-man rotations all season long, which means Podziemski's playing time has also been inconsistent. He's averaged 19 minutes over his last nine games, often playing in the 15-16 range. That's not much time to make an impact, especially if the shots aren't falling. Coming in and going 0-for-5 on 3s, as he did in a recent win over the New Orleans Pelicans , would test the confidence of even the most self-assured veteran, let alone a guard in his early 20s. But Podziemski has found a way to impact winning despite his dreadful early shooting numbers. He's averaged 7.2 points, 4.5 rebounds and 3.2 assists, and the Warriors are plus-60 in his minutes, which ranks fifth on the team. "I think it's the maturity piece. You do what's best for the team," Podziemski told CBS Sports. "You obviously have personal, individual goals that you want to live up to, just coming off the season I had last year. But I think an immature player would be, 'It's all about me, me, me, and it only works if I'm successful.' And I think through team success, individual success is a lot easier." While many players of his age and talent would be playing 30-plus minutes per night on a losing team, Podziemski needs to make an impact in whatever time Kerr decides to put him on the floor. "Obviously, 15-16 minutes, you want to play more, and that's just a given in competitive nature," Podziemski said. "But if you're winning, you know, what is there to say? Right? You could argue that X, Y, Z should play more or play less, but if you're winning, I think that kind of takes care of a lot of problems, a lot of questions." In terms of the poor shooting, Green recently issued a message to Podziemski through the media which essentially amounted to: who cares? To Green -- who has certainly struggled with his own jumper throughout his Hall of Fame career -- Podziemski does so many other important things on the court, that making shots is just a bonus and he needs to stop putting so much pressure on himself. "If the one thing that you're struggling with is your shot, but you're doing five or six other things great, I think that will outweigh your shot," Green said of Podziemski's struggles. "And he should appreciate that, lean into that. If he leans into that, the shots will fall." Podziemski has also received advice from the greatest shooter to ever live, who happens to be a couple lockers down from him. Curry pointed to his own preseason shooting woes, and that he's been in the league long enough to know that eventually he'll get on a hot streak and the average will settle where it's supposed to be. Podziemski has taken that to heart and is focusing on "the things I can control" in order to help the Warriors maintain one of the best records in the league. And as far as the deep rotation, Podziemski sees it as a blessing in the long run, even if it means his minutes get cut down a bit. "We all bring something different, and I think that's the difference between last year," Podziemski said. "Last year, there's only so many lineup combinations he could throw out there, given what players bring, what they need around them to be successful. And I think now we have so many diverse pieces that can be plugged and played in so many different lineups that it makes it easier."

Alabama left out of playoff as committee rewards SMU's wins over Crimson Tide's strong scheduleANN ARBOR, Mich. (AP) — Michigan's defense of the national championship has fallen woefully short. The Wolverines started the season ranked No. 9 in the AP Top 25 , making them the third college football team since 1991 to be ranked worse than seventh in the preseason poll after winning a national title. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Adam Pemble, AP journalist whose compassionate lens brought stories to life, dies at 52American Lithium Announces Intention to Voluntarily Delist Its Common Shares From Nasdaq Capital Market

ORLANDO, Fla. — It was a season of Iowa State comebacks. And fittingly, that's how it ended for the Cyclones. Game MVP Rocco Becht scored from a yard out on fourth-and-goal with 56 seconds remaining and No. 18 Iowa State capped the best season in school history by rallying past No. 15 Miami 42-41 in the Pop-Tarts Bowl on Saturday. Becht finished with 270 passing yards and three touchdowns for Iowa State (11-2), a program that entered this season — the 133rd year of Cyclone football — never having won more than nine games in a year. “If you look at this team, it’s really who they’ve been all year,” coach Matt Campbell said. The win marked the fourth time in 2024 that Iowa State got a winning score with less than two minutes remaining. For this one, the Cyclones rallied from a 10-point deficit in the second half — with Miami quarterback Cam Ward watching after a record-setting first half — to get win No. 11. Carson Hansen rushed for a pair of touchdowns for Iowa State. And as the MVP, Becht got the honor of choosing which flavor Pop-Tart was to be sacrificed in a giant toaster. “There's only one,” Becht said. “Cinnamon roll.” Ward passed for three touchdowns in his final college game, while Damien Martinez rushed for a career-high 179 yards for Miami (10-3), which dropped its sixth straight bowl game and lost three of four games to end the season — those three losses by a combined 10 points. "Disappointed that we couldn't pull out a victory," Miami coach Mario Cristobal said. “These guys have always fought and always competed and this was no exception. ... It's painful. It's as painful as it gets when you don't win. But there's a lot to build on.” NEBRASKA 20, BOSTON COLLEGE 15: Dylan Raiola passed for 228 yards and a touchdown as Nebraska built an 18-point lead through three quarters and hung on for its first bowl victory since 2015. Raiola hit Emmett Johnson with a 13-yard TD pass on fourth down with 3:02 remaining in the third quarter for a 20-2 edge and the Cornhuskers (7-6) held on for the win at Yankee Stadium. Raiola completed 23 of 31 passes in front of a sizable Nebraska crowd that celebrated the team's first bowl win since topping UCLA in the 2015 Foster Farms Bowl and first winning season since 2016. Raiola completed passes to 10 receivers, including Jahmal Banks, who finished with four receptions for 79 yards. Grayson James finished 25 of 40 for 296 yards as Boston College (7-6). MILITARY BOWL EAST CAROLINA 26, NC STATE 21: Rahjai Harris broke free for an 86-yard touchdown run with 1:33 remaining, giving East Carolina a pulsating victory over NC State in the Military Bowl in a game that descended into a wild brawl in the final minute in Annapolis, Md. Harris had 220 of ECU's 326 yards rushing, and his sensational sprint near the end of the game gave the Pirates (8-5) the lead back after they'd blown a 13-point advantage in the fourth. But after an interception by Dontavius Nash ended NC State's final drive, East Carolina's attempt to run out the clock was interrupted by large-scale fight between the two in-state rivals — who play each other again to start next season. Three players for ECU and five for NC State (6-7) were ejected. ECU trailed 21-20 and took over the ball at its own 14, and after two incompletions, the Pirates decided to run the ball with Harris. He had a good hole to the left for a big gain, then cut back past the final defender on his way to the end zone. ARIZONA BOWL MIAMI (OHIO) 43, COLORADO STATE 17: Kevin Davis had a career-high 148 yards rushing and two touchdowns on just nine carries, and Jordan Brunson also ran for two TDs to help Miami (Ohio) wrapped the season at 9-5 by beating Colorado State (8-5) in Tucson, Ariz. Davis scored on a 4-yard run with 12:35 left in the third quarter, Matt Salopek forced a fumble that was recovered by Silas Walters and quarterback Brett Gabbert's first rushing touchdown of the season — a 10-yard scramble that capped a 47-yard drive — made it 22-3 about 2 minutes later. UCONN 27, NORTH CAROLINA 14: Joe Fagnano threw for 151 yards and two touchdowns to help the Huskies (9-4) beat the Tar Heels (6-7) at Fenway Park, embarrassing incoming coach Bill Belichick's new team in his old backyard. Mel Brown rushed for 96 yards for UConn and Skyler Bell caught three passes for 77 yards, including a 38-yard touchdown that gave the Huskies a 10-0 first-quarter lead. Chris Culliver returned the ensuing kickoff 95 yards for a touchdown, but that would be Carolina's only production in the first half. TCU 34, LOUISIANA 3: Josh Hoover passed for four touchdowns as the Horned Frogs (9-4) routed the Ragin' Cajuns (10-4) in Albuquerque. Hoover was 20 for 32 for 252 yards with an interception. Eric McAlister had eight catches for 87 yards and a TD for the Horned Frogs. TCU's defense also had a solid day, holding Louisiana-Lafayette to 209 yards, including 61 on the game's final possession. LATE FRIDAY LAS VEGAS BOWL USC 35, TEXAS A&M 31: Jayden Maiava threw a 7-yard touchdown pass to tight end Kyle Ford with eight seconds left to give Southern California the victory over Texas A&M (8-5) in the Las Vegas Bowl. A graduate of Liberty High School in nearby Henderson and a transfer from UNLV, Maiava helped the Trojans (7-6) overcome a 17-point deficit. Get local news delivered to your inbox!MIAMI (AP) — The NBA is urging its players to take additional precautions to secure their homes following reports of recent high-profile burglaries of dwellings owned by Milwaukee Bucks forward Bobby Portis , Minnesota Timberwolves guard Mike Conley Jr. and Kansas City Chiefs teammates Patrick Mahomes and Travis Kelce. In a memo the NBA sent to its team officials, a copy of which was obtained by The Associated Press, the league revealed that the FBI has connected some burglaries to “transnational South American Theft Groups” that are “reportedly well-organized, sophisticated rings that incorporate advanced techniques and technologies, including pre-surveillance, drones, and signal jamming devices.” Conley's home was broken into on Sept. 15 when he was at a Minnesota Vikings game and jewelry was taken, officials told the Minneapolis Star-Tribune. Portis said his home was broken into on Nov. 2 and has offered a $40,000 reward for information related to the incident. The homes of Mahomes and Kelce were broken into within days of each other last month, according to law enforcement reports, and the NFL issued a similar warning memo to its teams this week. The NBA memo, relaying information from the FBI, said the theft rings “are primarily focused on cash and items that can be resold on the black market, such as jewelry, watches, and luxury bags.” The NBA, which has also been giving guidance to team security personnel, recommended that players install updated alarm systems with cameras and utilize them whenever leaving the home, keeping valuables in locked and secured safes, remove online real estate listings that may show interior photos of a home, “utilize protective guard services” during extended trips from the home and even suggested having dogs assist with home protection. Story continues below video “Obviously, it’s frustrating, disappointing, but I can’t get into too many of the details because the investigation is still ongoing,” Mahomes recently said. “But, obviously, something you don’t want to happen to anybody, but obviously yourself.” One of the break-ins involving the Chiefs players happened on a game day — Oct. 7 — and Portis was also playing a game when his home was robbed. “They took most of my prized possessions,” Portis said. AP NBA: https://apnews.com/NBA

MML Investors Services LLC purchased a new stake in Brandywine Realty Trust ( NYSE:BDN – Free Report ) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 20,573 shares of the real estate investment trust’s stock, valued at approximately $112,000. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BDN. State Street Corp raised its stake in shares of Brandywine Realty Trust by 2.2% in the third quarter. State Street Corp now owns 10,272,055 shares of the real estate investment trust’s stock valued at $55,880,000 after acquiring an additional 218,444 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Brandywine Realty Trust by 3.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,644,476 shares of the real estate investment trust’s stock valued at $11,847,000 after purchasing an additional 91,852 shares in the last quarter. Point72 Asset Management L.P. raised its position in Brandywine Realty Trust by 7,435.2% in the 2nd quarter. Point72 Asset Management L.P. now owns 2,087,242 shares of the real estate investment trust’s stock valued at $9,351,000 after purchasing an additional 2,059,542 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Brandywine Realty Trust by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 1,752,578 shares of the real estate investment trust’s stock worth $7,852,000 after purchasing an additional 8,884 shares in the last quarter. Finally, Systematic Financial Management LP boosted its stake in Brandywine Realty Trust by 36.4% in the third quarter. Systematic Financial Management LP now owns 954,325 shares of the real estate investment trust’s stock worth $5,192,000 after purchasing an additional 254,825 shares in the last quarter. 87.27% of the stock is currently owned by institutional investors and hedge funds. Wall Street Analyst Weigh In A number of research analysts recently issued reports on the company. Evercore ISI lifted their price target on Brandywine Realty Trust from $5.50 to $6.00 and gave the company an “in-line” rating in a report on Monday, September 16th. StockNews.com raised shares of Brandywine Realty Trust from a “sell” rating to a “hold” rating in a research note on Saturday. Brandywine Realty Trust Trading Down 1.8 % BDN stock opened at $5.51 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 2.05. Brandywine Realty Trust has a twelve month low of $3.85 and a twelve month high of $6.54. The company has a market cap of $951.39 million, a P/E ratio of -3.06 and a beta of 1.35. The business has a fifty day moving average of $5.51 and a 200-day moving average of $5.20. Brandywine Realty Trust ( NYSE:BDN – Get Free Report ) last announced its quarterly earnings data on Tuesday, October 22nd. The real estate investment trust reported ($0.96) earnings per share for the quarter, missing the consensus estimate of $0.24 by ($1.20). Brandywine Realty Trust had a negative return on equity of 24.59% and a negative net margin of 60.08%. The firm had revenue of $117.96 million for the quarter, compared to the consensus estimate of $120.00 million. During the same period in the prior year, the firm posted $0.29 earnings per share. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, equities research analysts expect that Brandywine Realty Trust will post 0.92 EPS for the current year. Brandywine Realty Trust Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 23rd. Shareholders of record on Wednesday, January 8th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 10.89%. The ex-dividend date is Wednesday, January 8th. Brandywine Realty Trust’s dividend payout ratio is presently -33.33%. About Brandywine Realty Trust ( Free Report ) Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 160 properties and 22.6 million square feet as of September 30, 2023 which excludes assets held for sale. See Also Five stocks we like better than Brandywine Realty Trust How to Invest in Insurance Companies: A Guide S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains What Are Dividends? Buy the Best Dividend Stocks How AI Implementation Could Help MongoDB Roar Back in 2025 3 Grocery Stocks That Are Proving They Are Still Essential Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon? Receive News & Ratings for Brandywine Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brandywine Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter .Discovery of new growth-directed graphene stacking domains may precede new era for quantum applications December 10, 2024 NYU Tandon School of Engineering Researchers discovered that three-layer graphene can naturally self-organize into specific stacking patterns (ABA/ABC domains) during growth on silicon carbide, eliminating the need for manual manipulation. This breakthrough could enable scalable production of quantum devices. Facebook Twitter Pinterest LinkedIN Email Graphene, a single layer of carbon atoms arranged in a two-dimensional honeycomb lattice, is known for its exceptional properties: incredible strength (about 200 times stronger than steel), light weight, flexibility, and excellent conduction of electricity and heat. These properties have made graphene increasingly important in applications across various fields, including electronics, energy storage, medical technology, and, most recently, quantum computing. Graphene' s quantum properties, such as superconductivity and other unique quantum behaviors, are known to arise when graphene atomic layers are stacked and twisted with precision to produce "ABC stacking domains." Historically, achieving ABC stacking domains required exfoliating graphene and manually twisting and aligning layers with exact orientations -- a highly intricate process that is difficult to scale for industrial applications. Now, researchers at NYU Tandon School of Engineering led by Elisa Riedo, Herman F. Mark Professor in Chemical and Biomolecular Engineering, have uncovered a new phenomenon in graphene research, observing growth-induced self-organized ABA and ABC stacking domains that could kick-start the development of advanced quantum technologies. The findings, published in a recent study in the Proceedings of the National Academy Of Sciences (PNAS) , demonstrate how specific stacking arrangements in three-layer epitaxial graphene systems emerge naturally -- eliminating the need for complex, non-scalable techniques traditionally used in graphene twisting fabrication. These researchers, including Martin Rejhon, previously a post-doctoral fellow at NYU, have now observed the self-assembly of ABA and ABC domains within a three-layer epitaxial graphene system grown on silicon carbide (SiC). Using advanced conductive atomic force microscopy (AFM), the team found that these domains form naturally without the need for manual twisting or alignment. This spontaneous organization represents a significant step forward in graphene stacking domains fabrication. The size and shape of these stacking domains are influenced by the interplay of strain and the geometry of the three-layer graphene regions. Some domains form as stripe-like structures, tens of nanometers wide and extending over microns, offering promising potential for future applications. "In the future we could control the size and location of these stacking patterns through pregrowth patterning of the SiC substrate," Riedo said. These self-assembled ABA/ABC stacking domains could lead to transformative applications in quantum devices. Their stripe-shaped configurations, for example, are well-suited for enabling unconventional quantum Hall effects, superconductivity, and charge density waves. Such breakthroughs pave the way for scalable electronic devices leveraging graphene's quantum properties. This discovery marks a major leap in graphene research, bringing scientists closer to realizing the full potential of this remarkable material in next-generation electronics and quantum technologies. The funding for this research came from the U.S. Army Research Office under Award # W911NF2020116. This research also included researchers from Charles University, Prague. Story Source: Materials provided by NYU Tandon School of Engineering . Note: Content may be edited for style and length. Journal Reference : Cite This Page :CONWAY, Ark., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), and its wholly-owned subsidiary, Centennial Bank (“Centennial”), announced it has established additional reserves for loan losses as a result of Hurricane Milton. On October 11, 2024, HOMB announced a $16.7 million reserve as a result of Hurricane Helene, which made landfall September 26, 2024. Upon announcement HOMB indicated the more recent and powerful Hurricane Milton, which made landfall on October 9, 2024, and caused the spin-off of more than two dozen tornados, would likely lead to an increase in this reserve amount. “Out of an abundance of caution, HOMB has decided to make an additional $16.7 million reserve following the second Florida hurricane, bringing our total hurricane reserve to $33.4 million for the year,” said John Allison, Chairman of HOMB. “The two hurricanes spanned across the third and fourth quarter and the amount of time it takes for customers to settle with insurance will no doubt increase, with two back-to-back events,” continued Allison. “We have approximately $110 million currently on deferral as a result of the two hurricanes and in keeping with our conservative nature, we feel as though this proactive move is a prudent and predictable course of action,” added Allison. Branches The Company currently has 76 branches in Arkansas, 78 branches in Florida, 58 branches in Texas, 5 branches in Alabama and one branch in New York City. About Home BancShares Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail banking plus related financial services to businesses, real estate developers, investors, individuals and municipalities. Centennial Bank has branch locations in Arkansas, Florida, Texas, South Alabama and New York City. The Company’s common stock is traded through the New York Stock Exchange under the symbol “HOMB.” The Company was founded in 1998. Visit www.homebancshares.com or www.my100bank.com for more information. General This release contains forward-looking statements regarding the Company’s plans, expectations, goals and outlook for the future, including future financial results. Statements in this press release that are not historical facts should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future events, performance or results. When we use words or phrases like “may,” “plan,” “propose,” “contemplate,” “anticipate,” “believe,” “intend,” “continue,” “expect,” “project,” “predict,” “estimate,” “could,” “should,” “would,” “on track” and similar expressions, you should consider them as identifying forward-looking statements, although we may use other phrasing. Forward-looking statements of this type speak only as of the date of this news release. By nature, forward-looking statements involve inherent risks and uncertainties. Various factors could cause actual results to differ materially from those contemplated by the forward-looking statements. These factors include, but are not limited to, the following: economic conditions, credit quality, interest rates, loan demand, real estate values and unemployment, including the ongoing impacts of inflation; the ability to identify, complete and successfully integrate new acquisitions; the risk that expected cost savings and other benefits from acquisitions may not be fully realized or may take longer to realize than expected; diversion of management time on acquisition-related issues; the availability of and access to capital and liquidity on terms acceptable to us; legislative and regulatory changes and risks and expenses associated with current and future legislation and regulations; technological changes and cybersecurity risks and incidents; the effects of changes in accounting policies and practices; changes in governmental monetary and fiscal policies; political instability, military conflicts and other major domestic or international events; the impact of recent or future adverse weather events, including hurricanes, and other natural disasters; disruptions, uncertainties and related effects on credit quality, liquidity and other aspects of our business and operations that may result from any future public health crises; competition from other financial institutions; potential claims, expenses and other adverse effects related to current or future litigation, regulatory examinations or other government actions; potential increases in deposit insurance assessments, increased regulatory scrutiny or market disruptions resulting from financial challenges in the banking industry; changes in the assumptions used in making the forward-looking statements; and other factors described in reports we file with the Securities and Exchange Commission (the “SEC”), including those factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 26, 2024. FOR MORE INFORMATION CONTACT: Donna Townsell Director of Investor Relations Home BancShares, Inc. (501) 328-4625Commonwealth Bank of Australia (OTCMKTS:CBAUF) Stock Passes Above Fifty Day Moving Average – Time to Sell?

TORONTO — Drake is taking his musical stylings Down Under with a short Australian tour set to kick off on the same date as rival Kendrick Lamar's Super Bowl halftime performance. The Toronto rapper announced the Anita Max Wynn Tour during a livestream Sunday night with Félix Lengyel, a Quebecois streamer known as xQc who used to play the video game Overwatch professionally. Drake's tour is named for his gaming alter ego. He says the tour will begin on Feb. 9, the same date Lamar is due to take the stage at Caesars Superdome in New Orleans, a connection Drake didn't make in the video. Drake says the tour will include stops in Melbourne, Sydney and the Gold Coast and will continue "until, like, March something." Representatives for Drake did not immediately respond to a request for more information about the tour or when tickets would go on sale. The tour follows a public diss battle between Drake and Lamar, which saw them exchange musical barbs in songs including "Taylor Made Freestyle" by Drake, and Lamar's "Not Like Us." Lamar's track is nominated for five Grammys, including record of the year and song of the year. Drake was not nominated for any Grammys this year, but his representatives did not immediately respond to questions on whether he submitted any work for consideration. In previous years he has opted not to. Meanwhile Drake and Kendrick will face off in several categories at the Billboard Music Awards, which measure chart success, streaming, airplay and social engagement Finalists for the Dec. 12 award show were announced Monday, and each nabbed eight nominations. They'll go head-to-head in two of those categories: top rap artist and top male rap artist. Drake is also a finalist in the top artist category, along with top male artist and top Billboard 200 artist. Lamar, meanwhile, is in contention for top Hot 100 songwriter and has two songs in the running for top rap song: "Not Like Us," and "Like That," a song with Future and Metro Boomin. A verse in "Like That" is seen as the first shot in the battle between Lamar and Drake. In it, Lamar scoffs at a lyric in Drake's song "First Person Shooter" that suggests that Lamar, Drake and featured artist J. Cole are the "big three" of rap. There's no big three, Lamar says. "It's just big me." This report by The Canadian Press was first published Nov. 25, 2024. Nicole Thompson, The Canadian PressWeek 14’s Sunday action brought a continuation of a few recent trends: The Panthers pushed another contender to the limit, the Jets continued to falter late (but got a big statistical performance out of Aaron Rodgers ), and Kirk Cousins struggled badly. ONE HAND ARE YOU KIDDING ME @byronmurphy 😱😱 📺: @NFLonFOX pic.twitter.com/eWHDOUl3Mk — Minnesota Vikings (@Vikings) December 8, 2024 The Athletic NFL writers Mike Jones, Ted Nguyen and Dan Pompei share their thoughts on all of these storylines and more. If you are Raheem Morris, are you benching Kirk Cousins and turning to Michael Penix Jr. ? Nguyen: Yes. Kirk Cousins can’t move and he’s turning the ball over — six interceptions in the last two games. There’s nowhere else to go with him. The hope was that he could keep the Falcons competitive while they develop Penix into the quarterback of the future, but the Falcons are 6-7, and their offense has looked terrible during a four-game losing streak. Sure, they still have a shot at winning the NFC South because it’s such a weak division, but they aren’t going anywhere. Penix is an older rookie and he’s had plenty of time to sit and learn the playbook. Give him experience. With four games against mediocre defenses left ( Raiders , Giants , Commanders , Panthers), now is a good time to make a quarterback switch rather than being influenced by sunk-cost fallacy. Advertisement Jones: It’s hard to say because we haven’t seen Penix in practices. We have no idea what his command of the offense is, or what his decision making is like. If Penix is comfortable and can take care of the football, then you have to give him a shot. Maybe simplifying the offense and leaning more heavily on the run game, while also throwing in some new wrinkles that Penix’s athleticism can offer, could help spark an offense that hasn’t had a touchdown pass in the four weeks and has eight interceptions during that span. If Penix isn’t ready, then the Falcons have to roll with Cousins. And if that’s the case, I’m ramping up the rushing attack and working hard to keep him in more manageable situations in hopes that it helps Cousins make better decisions and take better care of the ball. Pompei: There may be a jolt value in making a change, but it’s probably a stretch to think a player who has thrown five passes in the NFL can step into a playoff race and carry his team to a place that a veteran like Cousins cannot. Cousins is not playing well, but he’s always been a streaky performer who can go on a heater at any point. His experience is likely to be an asset in the final weeks of the season. Penix is completely unknown to the world outside the Falcons; their coaches and players have a better feel for his readiness. The only way Penix should be promoted is if Falcons players believe he gives them a better chance to win. They’ve lost three straight games by inches, but there’s no doubt the Carolina Panthers are showing new life. How bullish are you on this team for 2025? Pompei: They will have to do more than lose three close games to good teams to increase bullishness. Bad teams lose close games to good teams every week. Young’s improvement is heartening, but it will take much more than that for the Panthers, who have been one of football’s sorriest teams for two years, to make people think they can contend for a playoff spot in 2025. And many deservedly lack faith in their leadership. The Panthers need more talent and time, and they need to meet more challenges before they earn that trust. Advertisement Jones: The Panthers have definitely shown improvement on both sides of the ball. But they’re still 3-10, and they have plenty of holes on that roster. I think Carolina brass can draw encouragement from what they have seen out of Bryce Young and don’t need to look for another answer at quarterback. But I think we need to see what roster moves are made in free agency and the draft before we can be bullish in any way about Carolina being an X-factor in 2025. Nguyen: The way this franchise has misused assets in recent years keeps me from being too bullish on the Panthers’ future. I do like some of their young pieces, like Xavier Legette and Chuba Hubbard , and watching Bryce Young take advantage of his second chance has been awesome to watch. There is definitely potential for them to build on this core of players, and they’ll have a high first-round pick to work with. Dave Canales is a creative play designer and he has this team playing clean. Still, in the past we’ve seen teams improve late in the season then fail to build on the positive momentum. I’ll say I’m cautiously optimistic about the Panthers. The biggest thing is that it doesn’t look like they have to start over again at quarterback. On Sunday, Aaron Rodgers threw for 300 yards for the first time in 35 games. If he is unlikely to return to the Jets in 2025, how much interest should he draw from other teams this offseason? Jones: If a team is going to bring Aaron Rodgers aboard in 2025, they need to have a strong defense, quality offensive line and weapons for him to work with. I really don’t know which quarterback-needy team — New York Giants, Las Vegas Raiders, Tennessee Titans , New Orleans Saints — have all of those elements to offer. So, I don’t know that a one-year Rodgers rental would benefit anyone. Maybe the Tennessee Titans could use him as a bridge since Will Levis doesn’t appear to have what it takes — their roster isn’t bad. But I don’t see Rodgers wanting to go to a team that isn’t championship ready. Advertisement Nguyen: The problem is that you aren’t just getting a veteran who helps develop a young quarterback. Rodgers comes with a log of baggage. He needs to have players he trusts around him and it’s hard to earn his trust. He needs to run a very specific type of offense and he needs to have a lot of control. Not every offensive coordinator is going to want to cede that kind of control, especially if Rodgers isn’t producing at a high level. If Rodgers decides that he’s going to trust whatever system that he goes into and just be easier to deal with, the Vikings could be a good fit. Kevin O’Connell runs the same system Rodgers won two MVPs playing in with Green Bay , and it’s one of the best environments any quarterback could go into. Sam Darnold could be in line for a nice pay day and J.J. McCarthy might not be ready to take over as the starter yet. I think there might only be one or two teams that would be interested in signing Rodgers as a starter next season. Pompei: Even now, it’s crazy to think there are 32 better quarterbacks in the NFL than Rodgers. If you compare him to the other passers in the league, as opposed to the passer he once was, there will be a place for him in 2025. Rodgers is capable of performing significantly better than he did this year, when he was coming off a major injury. He could not rise above the dysfunction of the Jets, but he could be a contributor to a team that doesn’t need him to be its savior. If he finds a fit with strong ownership, solid coaching, offensive playmakers and blockers, and a stout defense, Rodgers can make an impact somewhere. The question: Does that team exist? (Top photo: David Berding / Getty Images)

As open enrollment for Affordable Care Act plans continues through Jan. 15, you’re likely seeing fewer social media ads promising monthly cash cards worth hundreds, if not thousands, of dollars that you can use for groceries, medical bills, rent and other expenses. But don’t worry. You haven’t missed out on any windfalls. Clicking on one of those ads would not have provided you with a cash card — at least not worth hundreds or thousands. But you might have found yourself switched to a health insurance plan you did not authorize, unable to afford treatment for an unforeseen medical emergency, and owing thousands of dollars to the IRS, according to an ongoing lawsuit against companies and individuals who plaintiffs say masterminded the ads and alleged scams committed against millions of people who responded to them. The absence of those once-ubiquitous ads are likely a result of the federal government suspending access to the ACA marketplace for two companies that market health insurance out of South Florida offices, amid accusations they used “fraudulent” ads to lure customers and then switched their insurance plans and agents without their knowledge. In its suspension letter, the Centers for Medicare & Medicaid Services (CMS) cited “credible allegations of misconduct” in the agency’s decision to suspend the abilities of two companies — TrueCoverage (doing business as Inshura) and BenefitAlign — to transact information with the marketplace. CMS licenses and monitors agencies that use their own websites and information technology platforms to enroll health insurance customers in ACA plans offered in the federal marketplace. The alleged scheme affected millions of consumers, according to a lawsuit winding its way through U.S. District Court in Fort Lauderdale that seeks class-action status. An amended version of the suit, filed in August, increased the number of defendants from six to 12: — TrueCoverage LLC, an Albuquerque, New Mexico-based health insurance agency with large offices in Miami, Miramar and Deerfield Beach. TrueCoverage is a sub-tenant of the South Florida Sun Sentinel in a building leased by the newspaper in Deerfield Beach. — Enhance Health LLC, a Sunrise-based health insurance agency that the lawsuit says was founded by Matthew Herman, also named as a defendant, with a $150 million investment from hedge fund Bain Capital’s insurance division. Bain Capital Insurance Fund LP is also a defendant. — Speridian Technologies LLC, accused in the lawsuit of establishing two direct enrollment platforms that provided TrueCoverage and other agencies access to the ACA marketplace. — Benefitalign LLC, identified in the suit as one of the direct enrollment platforms created by Speridian. Like Speridian and TrueCoverage, the company is based in Albuquerque, New Mexico. — Number One Prospecting LLC, doing business as Minerva Marketing, based in Fort Lauderdale, and its founder, Brandon Bowsky, accused of developing the social media ads that drove customers — or “leads” — to the health insurance agencies. — Digital Media Solutions LLC, doing business as Protect Health, a Miami-based agency that the suit says bought Minerva’s “fraudulent” ads. In September, the company filed for Chapter 11 protection from creditors in United States Bankruptcy Court in Texas, which automatically suspended claims filed against the company. — Net Health Affiliates Inc., an Aventura-based agency the lawsuit says was associated with Enhance Health and like it, bought leads from Minerva. — Garish Panicker, identified in the lawsuit as half-owner of Speridian Global Holdings and day-to-day controller of companies under its umbrella, including TrueCoverage, Benefitalign and Speridian Technologies. — Matthew Goldfuss, accused by the suit of overseeing and directing TrueCoverage’s ACA enrollment efforts. All of the defendants have filed motions to dismiss the lawsuit. The motions deny the allegations and argue that the plaintiffs failed to properly state their claims and lack the standing to file the complaints. The Sun Sentinel sent requests for comment and lists of questions about the cases to four separate law firms representing separate groups of defendants. Three of the law firms — one representing Brandon Bowsky and Number One Prospecting LLC d/b/a Minerva Marketing, and two others representing Net Health Affiliates Inc. and Bain Capital Insurance Fund — did not respond to the requests. A representative of Enhance Health LLC and Matthew Herman, Olga M. Vieira of the Miami-based firm Quinn Emanuel Urquhart & Sullivan LLP, responded with a short message saying she was glad the newspaper knew a motion to dismiss the charges had been filed by the defendants. She also said that, “Enhance has denied all the allegations as reported previously in the media.” Catherine Riedel, a communications specialist representing TrueCoverage LLC, Benefitalign LLC, Speridian Technologies LLC, Girish Panicker and Matthew Goldfuss, issued the following statement: “TrueCoverage takes these allegations very seriously and is responding appropriately. While we cannot comment on ongoing litigation, we strongly believe that the allegations are baseless and without merit. “Compliance is our business. The TrueCoverage team records and reviews every call with a customer, including during Open Enrollment when roughly 500 agents handle nearly 30,000 calls a day. No customer is enrolled into any policy without a formal verbal consent given by the customer. If any customer calls in as a result of misleading content presented by third-party marketing vendors, agents are trained to correct such misinformation and action is taken against such third-party vendors.” Through Riedel, the defendants declined to answer follow-up questions, including whether the company remains in business, whether it continues to enroll Affordable Care Act clients, and whether it is still operating its New Mexico call center using another affiliated technology platform. The suspension notification from the Centers for Medicare and Medicaid Services letter cites several factors, including the histories of noncompliance and previous suspensions. The letter noted suspicion that TrueCoverage and Benefitalign were storing consumers’ personally identifiable information in databases located in India and possibly other overseas locations in violation of the centers’ rules. The letter also notes allegations against the companies in the pending lawsuit that “they engaged in a variety of illegal practices, including violations of the (Racketeer Influenced & Corrupt Organizations, or RICO Act), misuse of consumer (personal identifiable information) and insurance fraud.” The amended lawsuit filed in August names as plaintiffs five individuals who say their insurance plans were changed and two agencies who say they lost money when they were replaced as agents. The lawsuit accuses the defendants of 55 counts of wrongdoing, ranging from running ads offering thousands of dollars in cash that they knew would never be provided directly to consumers, switching millions of consumers into different insurance policies without their authorization, misstating their household incomes to make them eligible for $0 premium coverage, and “stealing” commissions by switching the agents listed in their accounts. TrueCoverage, Enhance Health, Protect Health, and some of their associates “engaged in hundreds of thousands of agent-of-record swaps to steal other agents’ commissions,” the suit states. “Using the Benefitalign and Inshura platforms, they created large spreadsheet lists of consumer names, dates of birth and zip codes.” They provided those spreadsheets to agents, it says, and instructed them to access platforms linked to the ACA marketplace and change the customers’ agents of record “without telling the client or providing informed consent.” “In doing so, they immediately captured the monthly commissions of agents ... who had originally worked with the consumers directly to sign them up,” the lawsuit asserts. TrueCoverage employees who complained about dealing with prospects who called looking for cash cards were routinely chided by supervisors who told them to be vague and keep making money, the suit says. When the Centers for Medicare and Medicaid Services began contacting the company in January about customer complaints, the suit says TrueCoverage enrollment supervisor Matthew Goldfuss sent an email instructing agents “do not respond.” The lawsuit states the “scheme” was made possible in 2021 when Congress passed the American Rescue Plan Act in the wake of the COVID pandemic. The act made it possible for Americans with household incomes between 100% and 150% of the federal poverty level to pay zero in premiums and it enabled those consumers to enroll in ACA plans all year round, instead of during the three-month open enrollment period from November to January. Experienced health insurance brokers recognized the opportunity presented by the changes, the lawsuit says. More than 40 million Americans live within 100% and 150% of the federal poverty level, while only 15 million had ACA insurance at the time. The defendants developed or benefited from online ads, the lawsuit says, which falsely promised “hundreds and sometimes thousands of dollars per month in cash benefits such as subsidy cards to pay for common expenses like rent, groceries, and gas.” Consumers who clicked on the ads were brought to a landing page that asked a few qualifying questions, and if their answers suggested that they might qualify for a low-cost or no-cost plan, they were provided a phone number to a health insurance agency. There was a major problem with the plan, according to the lawsuit. “Customers believe they are being routed to someone who will send them a free cash card, not enroll them in health insurance.” By law, the federal government sends subsidies for ACA plans to insurance companies, and not to individual consumers. Scripts were developed requiring agents not to mention a cash card, and if a customer mentions a cash card, “be vague” and tell the caller that only the insurance carrier can provide that information, the lawsuit alleges. In September, the defendants filed a motion to dismiss the claims. In addition to denying the charges, they argued that the class plaintiffs lacked the standing to make the accusations and failed to demonstrate that they suffered harm. The motion also argued that the lawsuit’s accusations failed to meet requirements necessary to claim civil violations of the RICO Act. Miami-based attorney Jason Kellogg, representing the plaintiffs, said he doesn’t expect a ruling on the motion to dismiss the case for several months. The complaint also lists nearly 50 companies, not named as defendants, that it says fed business to TrueCoverage and Enhance Health. Known in the industry as “downlines,” most operate in office parks throughout South Florida, the lawsuit says. The lawsuit quotes former TrueCoverage employees complaining about having to work with customers lured by false cash promises in the online ads. A former employee who worked in the company’s Deerfield Beach office was quoted in the lawsuit as saying that senior TrueCoverage and Speridian executives “knew that consumers were calling in response to the false advertisements promising cash cards and they pressured agents to use them to enroll consumers into ACA plans.” A former human resources manager for TrueCoverage said sales agents frequently complained “that they did not feel comfortable having to mislead consumers,” the lawsuit said. Over two dozen agents “came to me with these complaints and showed me the false advertisements that consumers who called in were showing them,” the lawsuit quoted the former manager as saying. For much of the time the companies operated, the ACA marketplace enabled agents to easily access customer accounts using their names and Social Security numbers, change their insurance plans and switch their agents of record without their knowledge or authorization, the lawsuit says. This resulted in customers’ original agents losing their commissions and many of the policyholders finding out they suddenly owed far more for health care services than their original plans had required, the suit states. It says that one of the co-plaintiffs’ health plans was changed at least 22 times without her consent. She first discovered that she had lost her original plan when she sought to renew a prescription for her heart condition and her doctor told her she did not have health insurance, the suit states. Another co-plaintiff’s policy was switched after her husband responded to one of the cash card advertisements, the lawsuit says. That couple’s insurance plan was switched multiple times after a TrueCoverage agent excluded the wife’s income from an application so the couple would qualify. Later, they received bills from the IRS for $4,300 to cover tax credits issued to pay for the plans. CMS barred TrueCoverage and BenefitAlign from accessing the ACA marketplace. It said it received more than 90,000 complaints about unauthorized plan switches and more than 183,500 complaints about unauthorized enrollments, but the agency did not attribute all of the complaints to activities by the two companies. In addition, CMS restricted all agents’ abilities to alter policyholders’ enrollment information, the lawsuit says. Now access is allowed only for agents that already represent policyholders or if the policyholder participates in a three-way call with an agent and a marketplace employee. Between June and October, the agency barred 850 agents and brokers from accessing the marketplace “for reasonable suspicion of fraudulent or abusive conduct related to unauthorized enrollments or unauthorized plan switches,” according to an October CMS news release . The changes resulted in a “dramatic and sustained drop” in unauthorized activity, including a nearly 70% decrease in plan changes associated with an agent or broker and a nearly 90% decrease in changes to agent or broker commission information, the release said. It added that while consumers were often unaware of such changes, the opportunity to make them provided “significant financial incentive for non-compliant agents and brokers.” But CMS’ restrictions might be having unintended consequences for law-abiding agents and brokers. A story published by Insurance News Net on Nov. 11 quoted the president of the Health Agents for America (HAFA) trade group as saying agents are being suspended by CMS after being flagged by a mysterious algorithm that no one can figure out. The story quotes HAFA president Ronnell Nolan as surmising, “maybe they wrote too many policies on the same day for people who have the same income or they’re writing too many policies on people of a certain occupation.” Nolan continued, “We have members who have thousands of ACA clients. They can’t update or renew their clients. So those consumers have lost access to their professional agent, which is simply unfair.” Ron Hurtibise covers business and consumer issues for the South Florida Sun Sentinel. He can be reached by phone at 954-356-4071, on Twitter @ronhurtibise or by email at rhurtibise@sunsentinel.com.Semler Scientific (NASDAQ:SMLR) Trading Down 3.1% – Time to Sell?

Google's Year in Search report reveals that people around the globe were tuning in for updates on the US election, the latest iPhone release, major movie premieres, TikTok trends, style tips and more, the New York Post reported. Top searched items in different categories are mentioned below:

Olivia Hussey, star of 1968’s ‘Romeo and Juliet,’ dies at 73

As the data wave rides high more business are turning to riskier AI adoptions